Table 3.
Amphiphilic cyclodextrins derivatives and their potential application fields.
| Amphiphilic CDs | Systems | Potential applications | Refs. |
|---|---|---|---|
| Heptakis (2-O-oligo(ethyleneoxide)-6-hexadecylthio-)-β-CD (SC16OH) | Nanoparticles | Drug carriers (docetaxel) | [58] |
| 6-O-CAPRO-β-CD | Nanoparticles (nanospheres, nanocapsules, vesicles) | Drug carriers (paclitaxel, camptothecin) | [59,60] |
| βCD-C6/6-N-CAPRO-β-CD 6-N-MYRISTO-β-CD | Nanospheres Nanocapsules | Drug carriers (progesterone, camptothecin) | [35,36,60] |
| Oligoethyleneimine-βCD | CDplexes | Gene delivery | [61] |
| Heptakis[6-(2-amino-ethylthio)-6-deoxy-2-O-octylsulfanylpropyl]-β-cyclodextrin hepta-N-trifluoroacetate | CDplexes | Gene delivery | [62] |
| Heptakis[6-diBoc-guanidinoethylthio-2-O-(N-(ω-(p-methoxybenzamido)-PEG440-yl)-1′H-triazole-4’-yl-methyl)]-β-cyclodextrin | CDplexes | Gene delivery | [63] |
| Heptakis[6-deoxy-6-(2-(N’-(2-(N,N-di-(2-aminoethyl)amino)ethyl)thioureido)ethylthio)-2,3-di-O-hexanoyl] cyclomaltoheptaose | CDplexes | Gene delivery | [64] |
| Heptakis(6-dodecylthio-2-oligo(ethylenoxide)-β-cyclodextrin-2-(4-(phenyldiazenyl)phenoxy) acetate | Vesicles | Phototherapy | [65] |
| Heptakis(2-O-oligo(ethylene oxide)-6-hexylthio)-β-CD (SC6OH) | Nanoparticles | Phototherapy | [30] |
| SC6NH3-β-CD; SC16NH3-β-CD | Multilayer films | Photoresponsive multilayer films | [66] |
| Peptidyl-β-cyclodextrins | Assemblies with biological membranes | Artificial receptors | [67] |
| Amphiphilic β-cyclodextrins with n-dodecyl groups and n-hexadecyl chains on both faces | Assemblies with biological membranes | Artificial receptors | [28] |